Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study
Authors:
- Nefeli M. DimitropoulouNDNefeli M. Dimitropoulou
- Magdalena BeranMBMagdalena Beran
- Simone J. P. M. EussenSESimone J. P. M. Eussen
- Cassy F. DingenaCDCassy F. Dingena
- Pieter C. DagneliePDPieter C. Dagnelie
- Carla J. H. van der KallenCKCarla J. H. van der Kallen
- Annemarie KosterAKAnnemarie Koster
- Marleen M. J. van GreevenbroekMGMarleen M. J. van Greevenbroek
- Martijn C. G. J. BrouwersMBMartijn C. G. J. Brouwers
- Miranda T. SchramMSMiranda T. Schram
- Bastiaan E. de GalanBGBastiaan E. de Galan
- 7 November 2025
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 69 (2) , 364-373
Abstract
Aim/hypothesis Obesity and poor dietary habits are thought to explain high liver fat content in type 2 diabetes, but they are increasingly common among individuals with type 1 diabetes. Whether people with type 1 diabetes are at an increased risk of liver fat accumulation remains unclear. We aimed to compare liver fat content in people with type 1 diabetes, with type 2 diabetes and without diabetes. Methods Data were derived from The Maastricht Study, a population-based cohort study. We matched people with type 1 diabetes to those with type 2 diabetes and those with normal glucose metabolism (1:2:2 matching) based on BMI, sex, age and educational level. MRI was used to estimate liver fat content. Liver fat data were log-transformed. We performed multiple linear regression analyses to compare the liver fat content between the three groups, adjusted for potential confounders including CVD risk factors, lifestyle, dietary factors, insulin use and estimated glucose disposal rate (eGDR). Results We included 29 individuals with type 1 diabetes, 58 with type 2 diabetes and 58 with normal glucose metabolism. The median liver fat content in type 1 diabetes was lower than in type 2 diabetes (2.1% [IQR 1.1–3.3] vs 4.9% [IQR 2.2–9.6], p=0.001), but did not differ from that in individuals with normal glucose metabolism (2.6% [IQR 1.8–3.8], p=0.064). The difference in liver fat content between the two diabetes groups was independent of BMI, lifestyle factors, CVD risk factors and dietary factors, but attenuated after adjustment for eGDR and insulin treatment. Conclusions/interpretation The liver fat content of individuals with type 1 diabetes was comparable to that of people without diabetes and lower than that in those with type 2 diabetes. This difference was independent of the level of obesity, dietary factors and other potential confounders, but was partially explained by insulin sensitivity and insulin treatment. Graphical AbstractKeywords
This publication has 31 references indexed in Scilit:
- Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetesJournal of Diabetes and its Complications, 2024
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive SummaryDiabetologia, 2024
- MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitusDiabetes & Metabolism, 2023
- Relationship between NAFLD and coronary artery disease: A Mendelian randomization studyHepatology, 2022
- Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetesEuropean Journal of Internal Medicine, 2022
- Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetesDiabetes Research and Clinical Practice, 2022
- Intrahepatic lipid content is independently associated with soluble E-selectin levels: The Maastricht studyDigestive and Liver Disease, 2022
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causalityDiabetologia, 2019
- The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbiditiesEuropean Journal of Epidemiology, 2014
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetesJournal of Hepatology, 2010